The Lung in Autoimmune Diseases
- 1st Edition, Volume 17 - February 16, 2022
- Imprint: Elsevier
- Editors: Fabiola Atzeni, Jose Gomez-Puerta, Jacobo Sellares
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 1 0 8 3 - 5
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 1 0 8 4 - 2
The Lung in Autoimmune Diseases, Volume Seventeen identifies and describes the role of the lung in the most common systemic autoimmune diseases. From disease patterns, progno… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Lung in Autoimmune Diseases, Volume Seventeen identifies and describes the role of the lung in the most common systemic autoimmune diseases. From disease patterns, prognosis and risks to treatment, this book provides a comprehensive approach for the role of the lung in autoimmune diseases and the influence of autoimmune disease on the lung’s functionality. In recent years, there is increasing knowledge in the field, including lung infection in early disease stages, mechanisms involved in lung damage, and new treatments. Recognition of lung involvement and implementation of some specific therapies is an important issue for clinicians dealing with systemic autoimmune diseases.
- Provides a comprehensive review of the different patterns of pulmonary involvement in systemic autoimmune diseases
- Describes new, targeted therapies for the treatment of systemic autoimmune diseases, including anti-fibrotics, biologics and vasodilators
- Gives insights on the prognosis of patients suffering from systemic autoimmune diseases
- Depicts better definitions of types of lung involvement in patients with an underlying systemic autoimmune disease
Immunologists, rheumatologists, haematologists, cardiologists, post graduate students and those working in autoimmune diseases, general medicine and hospital/pharmaceutical management. Pulmonologists, Medical/scientific management and pharmaceutical companies
- Cover image
- Title page
- Table of Contents
- Handbook of Systemic Autoimmune Diseases
- Copyright
- Dedication
- Contributors
- Chapter 1. Interstitial pneumonia with autoimmune features
- Epidemiology
- IPAF classification
- Mechanisms of disease
- Prognosis
- Treatment considerations
- Criticisms and potential shortcomings of the IPAF designation
- Conclusions
- Take home message
- Chapter 2. Interstitial lung disease and rheumatoid arthritis
- Introduction
- Risk factors and pathogenesis
- Clinical manifestations
- Diagnostic imaging
- Different diagnostic methods
- Therapy
- Conclusions
- Take-home messages
- Chapter 3. Lung involvement in SLE
- Pleural involvement
- Interstitial lung disease
- Pulmonary arterial hypertension
- Diffuse alveolar hemorrhage and pulmonary vasculitis
- Acute lupus pneumonitis
- Shrinking lung syndrome
- Chapter 4. Sjogren's syndrome and lung involvement
- Introduction
- Airway disease
- Interstitial lung disease
- Other pulmonary manifestations
- Chapter 5. Lung involvement in systemic sclerosis
- Epidemiology
- Pathogenesis
- Clincal presentation
- Diagnosis of ILD
- Screening for ILD
- ILD monitoring and progression
- Prognosis
- Treatment
- COVID-19 and systemic sclerosis
- Summary
- Take-home messages
- Chapter 6. Inflammatory myopathy, mixed connective tissue disease, and antisynthetase syndrome
- Introduction
- The lung in inflammatory myopathies
- The lung in mixed connective tissue disease
- Chapter 7. Lung involvement in ANCA-associated vasculitis
- Introduction
- Pulmonary manifestations shared among all types of AAV
- Pulmonary manifestations primarily seen in GPA and EGPA
- Pulmonary manifestations primarily seen in GPA
- Pulmonary manifestations primarily seen in EGPA
- Treatment of lung involvement in ANCA-associated vasculitis
- Conclusions
- Chapter 8. The lung in autoimmune diseases: sarcoidosis
- Introduction
- Lymphatic involvement
- Parenchymal lung involvement
- Pulmonary vascular involvement
- Diagnosis of sarcoidosis
- Treatment
- Conclusion
- Take home messages
- Chapter 9. COVID-19 and lung involvement
- Introduction
- Epidemiology
- Virology
- Transmission
- Pathogenesis
- Clinical features
- Laboratory findings
- Imaging findings
- Pathology findings
- Diagnosis
- Management
- Conclusion
- Take-home messages
- Index
- Edition: 1
- Volume: 17
- Published: February 16, 2022
- Imprint: Elsevier
- No. of pages: 228
- Language: English
- Paperback ISBN: 9780323910835
- eBook ISBN: 9780323910842
FA
Fabiola Atzeni
Fabiola Atzeni, MD, PhD is currently Full Professor and Head of the Rheumatology Unit, University of Messina, Messina, Italy. Her clinical and research interest lies in immunotherapies in autoimmune diseases with particular focus on the investigation and management of differential response to biological therapies in rheumatoid arthritis (RA) and Spondyloarthritis (SpA), and cardiovascular aspects of the different rheumatic diseases with particular emphasis on arteriosclerosis. Dr. Atzeni has co-authored over 400 publications in peer-reviewed journals and several book chapters, is a regular reviewer for several international journals. She is involved in several international and national meetings focused on cardiovascular and infection aspects.
Affiliations and expertise
Full Professor and Head of Rheumatology Unit, University of Messina, Messina, ItalyJG
Jose Gomez-Puerta
Jose A. Gómez-Puerta is a Specialist in Internal Medicine and Rheumatology and Ph.D. in Biopathology by the University of Barcelona. He received further training in the Rheumatology Unit of Guy’s Hospital, London, UK, and the Lupus Unit, St. Thomas’ Hospital, London, UK, in 1997 and 2001, respectively. He also finished the Master in Autoimmune Diseases at Universidad de Barcelona and moved for an appointment as Post-Doctoral Research Fellow at Brigham and Women’s Hospital at Harvard Medical School, Boston, USA from 2011 to 2014. In 2014, Dr Gómez-Puerta obtained his degree in Master of Public Health at Harvard School of Public Health, Boston. USA. His work has focused on the study of Autoimmune and immune mediated diseases and he has published more than 100 original papers, brief notes or reviews in peer-reviewed journals and over 160 communications in national and international meetings. Currently, Dr Gómez-Puerta is the Head of Department of Rheumatology At Hospital Clinic, Barcelona and associate professor of Rheumatology at University of Barcelona, Spain
Affiliations and expertise
Specialist in Internal Medicine and Rheumatology, University of Barcelona, Barcelona, Catalonia, SpainJS
Jacobo Sellares
Dr. Jacobo Sellarés Torres is a recognized researcher in chronic respiratory diseases, and especially in diffuse interstitial lung diseases (DILD). He is coordinator of the Multidisciplinary Program of ILD at Hospital Clínic, Barcelona, which has been recognized by a variety of organizations, such as the Spanish Society of Pneumology (SEPAR), Orphanet, the European Reference Network (ERN) and the International Sarcoidosis Society (WASOG). Dr. Sellarés Torres belongs to the "Inflammation and repair of respiratory diseases" team of Area 2 of IDIBAPS, Barcelona who specializes in the methodology of systems biology and diseases chronic respiratory diseases. Dr. Sellares is also a research member of the Barcelona Research Network (BRN) and of the CIBER of respiratory diseases (CIBERES), and he actively collaborates in different national and international EPID registration networks. Dr. Sellarés has been a mentor of Respirarory Fellows (Hospital Clinic) since 2019 and reviewer for "Consell Tècnic de Medicina del Consell Català de la Formació Continuada (FC) de les Professions Sanitàries (PS), Departament de Salut de la Generalitat de Catalunya".
Affiliations and expertise
Pneumology Department, Hospital Clinic de Barcelona, SpainRead The Lung in Autoimmune Diseases on ScienceDirect